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Mechanisms of uremic inhibition of phagocyte reactive species produc-
tion: Characterization of the role of p.cresol. It is generally recognized
that the uremic syndrome results in a depression of immune function, but
the uremic solutes responsible remain largely unidentified. In this study,
the effect of 18 known uremic retention solutes, including urea and
creatinine, on hexose monophosphate shunt (HMS)-dependent glucose-
1-C'4 utilization (G1C-U), chemiluminescence production (CL-P) and
flow cytometric parameters (FCP) of respiratory burst and phagocytosis
were evaluated in granulocytes and/or monocytes. Among the compounds
studied, only p-cresol depressed whole blood respiratory burst reactivity
(G1C-U, CL-P) dose dependently at concentrations currently encoun-
tered in end-stage renal disease (ESRD) (P < 0.05 from 5 rg/ml on). The
effect of p-cresol was enhanced by increasing incubation times from 10 to
120 minutes. HMS activity of isolated packed erythrocytes remained
unaffected. FCP of respiratory burst activity (Bursttest', expressed as log
fluorescence units, LFU) revealed a marked depression in the presence of
p-cresol (from 700 167 to 291 128 LFU for granulocytes, from 278
102 to 146 52 LFU for monocytes, P < 0.01), whereas particle ingestion
(PhagotestR) remained unaffected. Cell-free myeloperoxidase activity was
also markedly depressed in the presence of p-cresol. Polarity based
HPLC-elution of a standard solution containing all the solutes studied,
using a gradient from 100% formic acid to 100% methanol during 60
minutes, revealed elution of p-cresol after 46.6 minutes, pointing to its
relative hydrophobicity. Conjugation of p-cresol to p-cresylsulfate anihi-
lated the depressive effect of p-cresol on granulocyte function, and at the
same time caused a shift in HPLC-elution pattern to a less lipophilic
range. It is concluded that p-cresol, in a concentration range currently
observed in renal failure, is a hydrophobic uremic retention solute
depressing phagocyte functional capacity. This effect is not related to
defective particle ingestion, but rather to a depression of the metabolic
axis involving protein kinase C, NADPH-oxidase and myeloperoxidase,
resulting in a lower energy delivery requirement by the HMS.
Infection remains a primary source of morbidity and mortality
in end-stage renal disease (ESRD) [1—3]. Energy delivery to
NAD(P)H-oxidase by glucose breakdown by the hexose mono-
phosphate shunt (HMS), during the respiratory burst, resulting in
the production of free radical species for the destruction of
bacteria, is depressed in ESRD [4—6], and this has been related to
the propensity of uremic patients for infection [7—9].
Some studies suggest that uremic biological fluids depress
granulocyte function [10, 11], but the identity of the compounds
responsible remains unclear and contradictory [12].
Received for publication April 29, 1994
and in revised form August 16, 1994
Accepted for publication August 16, 1994
© 1995 by the International Society of Nephrology
In this study, the influence of a panel of several known uremic
retention solutes (N = 18) on granulocytic glucose breakdown in
CO2 by the HMS was evaluated after challenge of the metabolism
of granulocytes. The results obtained were matched with chemi-
luminescence production and parameters of free radical produc-
tion per cell estimated by flow cytometric analysis. The same
solutes were also evaluated by HPLC for their hydrophilicity!
hydrophobicity. A dose dependent depression of CO2- and chemi-
luminescence production was found for p-cresol, which is corrob-
orated by flow cytometric analysis. Phenol had a similar effect, but
only at concentrations exceeding those currently encountered in
uremia.
Methods
Sample collections
All blood samples were collected from subjects with normal
renal function (serum creatinine < 13 .tgIml, creatinine clearance
> 80 ml/min).
Evaluations were performed on heparinized whole blood (Ca-
heparinate 1/8 in hemagglutination buffer, 800 IU in 200 It1, added
to 10 ml blood), unless for experiments on isolated erythrocytes or
granulocytes.
Isolated granulocytes were obtained as described [13]. After
washing, cells were suspended in autologous plasma (± 5 X 106
cells/ml, >90% granulocytes). Granulocyte viability (Trypan blue)
was positive in >95% of the cells.
Isolated erythrocytes were obtained after centrifugation, re-
moval of the supernatant buffy coat, and resuspension in autolo-
gous plasma at the same hematocrit as in blood.
Evaluation methods
Granulocyte glucose-1-14C consumption. The principle of the
assay has been described in detail [4]. The rise in CO2 production
( C02) after the addition of challenging agents is reported.
Latex, zymosan and Staph A suspensions were prepared as
described [4]. PMA was dissolved in dimethylsulfoxide (DMSO)
(Sigma Chemical Co., St. Louis, MO, USA) to obtain a stock
solution (10 Lg/ml), and in the experiments 10 pA were added to
50 pi of blood. HMS activity is not phagocyte-specific, since
erythrocytes can utilize glucose in the same metabolic pathway.
Addition of latex, zymosan, Staph A or PMA to erythrocytes
revealed no difference in red cell CO2 production with or without
agonists, and thus the contribution of erythrocytes on the z CO2
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between challenged and baseline values were insignificant. Like-
wise, in preliminaiy studies, interference on glucose-1-'4C con-
sumption of shifts in sodium, glucose, potassium, calcium and
phosphorus concentration within physiologic ranges was excluded
[4], The pH of the samples before and at the end of incubation
ranged between 7.6 and 8.2, but shifts in the pH of the medium
between these limits gave no differences in stimulated response.
For this method of estimation of CO2 production, the possibil-
ity of quenching was considered by the calculation of two param-
eters: (1) the Spectral Index of the Sample (SIS); and (2) the
transformed Spectral Index of the External Standard Spectrum
(tSIE), based on the Compton spectrum, induced in the sample by
an external standard source (133Ba).
Chemiluminescence production. For each evaluation, either 100
l of HBSS or of Staph A suspension were added to 50 pJ of
whole blood, as well as 500 ,.tl of a luminol test solution (56
mol/liter). The test tube was immediately processed into a
luminescence analyzer (Lumicon, Hamilton, Switzerland; 425
nm). The photon counting value (expressed in relative light units,
RLU) was established (counting interval 30 seconds, total recy-
cling time 30 mm), together with the number of counts (CPM),
calculated integral of counts over the total cycling time (CPM),
and peak value (CPS).
Influence on myeloperoxidase activity. Myeloperoxidase (0.1 ml;
Sigma) at a concentration of 0.125 g/ml and H2O2 30% 1 ma'i
(0.05 ml) were added to 0.65 ml Hanks solution and 0.1 ml
luminol solution (10 mg luminol/1 ml NaOH 0.1 M, 1/4000 diluted
in Hanks), and luminol-enhanced chemiluminescence was evalu-
ated [14].
Flow cytometric analyses. Analysis of phagocytosis. Fresh hepa-
rinized blood was placed on ice, vortexed, and 100 l aliquoted to
the bottom of a 5 ml tube. Phagocytosis was induced by adding 20
jd of stabilized opsonized FITC-labeled E. coli (Phagotest',
Orpegen, Heidelberg, Germany; 1 X 109/ml). After vortexing
again, the samples were incubated 10 minutes at 37°C, put on ice,
and 100 pi ice cold quenching solution [15] were added to
eliminate attached bacteria. After washing twice (5 ruin, 250 g,
4°C), submission to a formaldehyde and diethylene glycol lysing
solution (Orpegen), and washing, 100 1i DNA-staining propidium
iodide in PBS was added (10 mm at 0°C), and samples were read
within 30 minutes.
Blue-green fluorescence analyses (488 nm) were performed on
a flow cytometer (FACScan, Becton-Dickinson, Erembodegem,
Belgium) with an Argon laser. The "Live Gate" was set in the red
fluorescence histogram on cells with a DNA content compatible
with that of human diploid cells. Fluorescence was standardized
daily by microbeads (CalibriteTM particles, Becton Dickinson),
and amplification and voltage were kept constant for all proce-
dures. Analysis was performed on 10,000 viable leukocytes sepa-
rated according to size and cellularity. The mean fluorescence
intensity (number of ingested bacteria), was expressed as log
fluorescence units (LFU). For this, a region of interest was set on
the green fluorescent cells for comparison against the assay
control at 0°C.
Analysis of respiratoly burst. Blood sample preparation was
identical to that used for phagocytosis, but at the end of the 10
minute incubation at 37°C, 20 .d of substrate solution (BursttestR,
Orpegen; dihydrorhodamine 123-DHR) was added to evaluate
oxidation, read as brightly fluorescent rhodamine [16].
Table 1. Individual solutes under evaluation for screening of influence
on PMNL CO2 production
Name
Concentrationa
pg/mi
Molecular
daitons References
Arginine
j3-endorphin
40
10—'
174.2
3705.0
19
20
Creatinine 100 113.1 21
Dimethylamine 4 45.1 22
Guanidinosuccinic acid 20 175.1 23
Hippuric acid 300 179.2 24, 25
Indoxyl sulfate 60 251.3 26, 27
Methylguanidine 10 73.1 28
0-hydroxyhippuric acid 2 195.2 29, 30
P-cresol 30 108.1 31, 32
Phenol 10 94.1 32
Pseudouridine 20 244,2 21, 27
Spermidine 100 145.2 33
Spermine 100 202.3 33
Tiyptophan 5 204.0 27
Tyrosine 20 181.7 27
Urea 2000 60.1 34
Uric acid 100 168.1 21
a Concentration after separate addition of each compound to whole
blood
HPLC procedure. A standard solution containing the uremic
solutes under study was fractionated by high-performance liquid
chromatography [17, 18] to define the elution characteristics of
solutes with a potential inhibitory capacity on granulocyte func-
tion.
Individual peaks were recorded by UV absorption (254 nm;
Uvicord SIT 2238, Pharmacia, Lund, Sweden), fluorescence emis-
sion (excitation/emission 280/340 nm; Fluorescence HPLC mon-
itor RF-530, Shimadzu, Kyoto, Japan) and/or light scattering
analysis (Sedex 45 SFC, Sedere, Vitry sur Seine, France).
Spectrum analysis. Light absorption spectrum analysis of the
individual compounds was performed in the ultraviolet and visible
range by a photodiode array detector (HP1O4OA, Hewlett-Pack-
ard, Waldbronn, Germany).
Study design
Screening of solutes. All 18 solutes (Table 1) were purchased
from Sigma. Heparinized blood samples were submitted to a
paired evaluation, with and without each of these 18 individual
compounds. The compounds were first diluted in water, and then
lyophilized, so that dry solute was added to the whole blood
samples. The concentrations used were in the range of those
reported for ESRD [19—34]. In view of the excessively elevated
concentrations of o-hydroxyhippuric acid in isolated patients [35],
six samples were treated with 100 g/ml of this solute, in addition
to the concentration of 2 iWml mentioned in Table 1.
After addition of the solute, the whole blood samples were
maintained in a closed test tube for 10 minutes at 37°C in a shaker,
until equilibration. The CO2 response to latex, zymosan and PMA
was evaluated. For p-cresol, E. coli particle ingestion and subse-
quent oxidation were measured in addition by FACScan' at a
concentration of 0 and 30 .ig/ml.
Dose-response curves. A dose-response evaluation of CO2 pro-
duction and chemiluminescence was obtained for 3-endorphin (0,
0.5 X 10_i, 10_i and 8 X 10_I sg/ml), creatinine (0, 50, 100 and
200 g/ml), phenol (0, 5, 10 and 20 g/ml), spermidine (0, 25, 100
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Table 2. Response ('4C02 production) to latex, zymosan and PMA without (C) and with (E) the addition of various salutes to whole blood
Compound (N)
Latex Zymosan PMA
C E C E C F
Arginine (8) 54 6 54 8 78 9 78 11 80 10 85 l3'
13-endorphin (6) 57 5 53 5 78 17 71 15 73 8 76 7
Creatinine (8) 41 6 39 6 70 12 63 10 63 9 67 8
Dimethylamine (8) 49 5 43 5 66 6 66 6 68 6 66 6
Guanidinosuccinic acid (8) 56 14 56 15 92 22 92 24 83 21 80 20
Hippuric acid (6) 66 7 67 8 99 12 99 15 98 14 99 13
Indoxyl sulfate (8) 62 13 55 13 98 22 96 25 98 20 97 20
Methylguanidine (8) 58 6 55 9 78 7 72 5 79 11 82 11
0-hydroxyhippuric acid (8) 48 6 47 6 72 7 67 7 69 8 70 6
P-cresol (10) 39 3 18 3" 53 7 33 5b 74 14 58 ioa
Phenol (8) 50 6 44 4 69 14 64 10 65 8 66 8
Pseudo-uridine (8) 50 6 47 7 73 7 71 5 72 8 70 9
Spermidine (6) — — 64 17 66 18 — —
Spermine (9) 51 6 50 6 73 9 82 9 77 10 85 10
Tryptophan (7) 39 8 43 9 61 9 71 10 56 10 60 8
Tyrosine (6) 61 12 51 9 81 11 81 7 79 11 87 10
Urea (6) 41 8 42 8 74 16 83 14 66 12 79 9
Uric acid (6) 66 7 58 7 99 12 99 12 99 14 99 13
Abbreviations are: C, control; E, experiment. Data are expressed as disintegrations per minute (DPM X 10) in whole blood samples. Values indicate
the difference between challenge and baseline.
aP < 0•05, bp < 0.01 vs. C
and 800 g/ml), spermine (0, 25, 100 and 800 g/ml) and urea (0,
1.5, 3 and 6 mg/mI), and only the response to Staph A was
evaluated. For p-cresol, dose-response curves towards latex, zy-
mosan, and/or Staph A were obtained at concentrations of 0 to 50
g/ml (CO2 production and chemiluminescence), as well as
cell-free myeloperoxidase activity.
To evaluate quenching by p-cresoi absorption, spectrum anal-
ysis of p-cresol was performed.
Influence of incubation time (p-cresol). After incubation for 10,
60 and 120 minutes with 5 and 20 sg/ml p-cresol, CO2 production
and chemiluminescence (Staph A) were estimated.
Comparison of p-cresol and o-cresol. The same blood samples
were submitted to p-cresol, o-cresol, and p-cresol and o-cresol
together (30 .tglml, 10 mm), and CO2 production was evaluated.
0-cresol is not a uremic solute, but was used in this study for its
characteristics that closely mimic those of p-cresol.
Studies with p-cresylsulfate. To estimate whether the main
conjugate of p-cresol, p-cresylsulfate, influenced granulocyte func-
tional capacity, p-cresylsulfate was prepared chemically [36].
Purity was controlled by mass spectrometly and HPLC. CO2
production in response to Staph A was evaluated after a 10
minute incubation with p-cresol, p-cresylsulfate or p-cresol and
p-cresylsulfate (each 30 g/ml) together.
HPLC pattern of uremic solutes used for screening. A standard
solution containing the compounds used for the screening of their
effect on granulocyte function was submitted to HPLC. The
composition of the standard solution was as follows: creatinine,
33.3 g/ml; hippuric acid, 250 jLg/ml; indoxyl sulfate, 15 sg/ml;
o-hydroxyhippuric acid, 1.33 g/ml; p-cresol, 10 Lg/ml; phenol,
33.3 ag/ml; pseudouridine, 6.6 g/ml; tryptophan, 1.33 tg/ml;
tyrosine, 10 ig/ml; and uric acid, 333 .tgIml. A combined evalu-
ation by UV absorption and fluorescence emission was under-
taken. The remaining solutes (arginine, 2 mg/mI; /3-endorphin,
10_i g/ml; dimethylamine, 80 jsg/ml; guanidinosuccinic acid, 2
mg/ml; methylguanidine, 2 mg/mI; spermidine, 1.5 mg/mI; sper-
mine, 1.5 mg/mI; and urea, 200 j.Lg/ml) were submitted to light
scattering analysis.
Statistical analyses
Data are expressed as means SEM. Comparisons were made
by variance analysis (ANOVA) followed by paired or unpaired
Student's t-test (P < 0.05 was considered as significant).
Results
Screening of solutes
The glucose, Nat, K, urea and creatinine concentrations of
the normal blood samples used in the screening evaluation were
respectively: 1.02 0.04 mg/mI, 140.0 0.3 imol/ml, 4.3 0.1
jsmol/ml, 0.20 0.01 mg/mi and 11.5 0.5 p.g/ml. The addition
to whole blood of 18 known uremic solutes caused no significant
changes in the CO2 production in the basal resting state. The
effect on the response to latex, zymosan and PMA is illustrated in
Table 2. The most striking result was a consistent decrease in
cellular response versus latex, zymosan and PMA in the presence
of p-cresol. No significant changes were observed for most other
compounds. Some caused a slight increase in the metabolic
response [arginine (PMA) and spermine (zymosan)]. CO2 pro-
duction in response to zymosan at 100 g/ml o-hydroxyhippuric
acid showed no change: 100.6 11.8 versus 102.2 6.3 DPM,
P = NS).
Quenching of radioactivity emission by p-cresoi was excluded by
the calculation of SIS and tSIE (SIS = 59.0 0.6 with and 58.5
0.4 without 30 JLg/ml p-cresol, tSIE, respectively, 452.7 0.9 and
451.1 1.0; P = NS; N = 12).
The influence of p-cresol was also studied on isolated erythro-
cytes, but here no differences were found (3991 1091 without vs.
3879 1058 DPM with 30 jsg/ml p-cresol; N = 7, P = NS). In
contrast, on isolated granulocytes (N = 7), the response in
presence of p-cresol was similar to that observed in whole blood
(latex —59%, zymosan —40%, Staph A —47%, PMA —21%; P <
0.05).
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Fig. 1. Typical histograms of granulocytes obtained with FagotestR in the
presence (lane 1) or absence of p-cresol (30 pg/mI) (lane 2), and with
Bursttest' in the presence (lane 3) or absence of p-cresol (lane 4). P-cresol
induces no differences in fluorescence emission in response to FagotestR.
The response to Bursttest' in the presence of p-cresol is, however,
markedly lower (shift to the left).
Evaluation of E. coli phagocytosis by Phagotest' and FACScan
(N = 6) revealed no difference in percentage phagocytizing
granulocytes (no vs. 30 .tg/mI p-cresol, 95.1 2.8 vs. 95.3
2.7%), phagocytizing monocytes (67.5 1.9 vs. 65.0 4.1%),
mean fluorescence (E. coli/cell) per granulocyte (3613 1011 vs.
3254 876 LFU), and fluorescence per monocyte (2447 355 vs.
2201 539 LFU; P = NS each time).
There were, however, marked differences for indices of oxida-
tion (N = 8). In Figure 1 a typical histogram of the BursttestR with
and without p-cresol is illustrated. Although no significant differ-
ences in the percentage of oxidizing granulocytes or monocytes
were observed, (97.4 2.2 vs. 97.0 2.4 and 48.9 11.1 vs. 41.9
7.8%), there was a marked decrease in respiratory burst-related
mean fluorescence emission (Fig. 2): from 700 167 to 291 128
LFU for granulocytes, and from 278 102 to 146 52 LFU for
monocytes (P < 0.01 for both).
Dose-response curves
The addition of different quantities of p-cresol resulted in a
progressive decrease in both CO2 production (Fig. 3; N = 12) and
chemiluminescence response (Figs. 4 and 5; N = 8). A significant
decrease was observed at the lowest concentration of 5 j.g/ml.
The possibility of quenching of luminescent light was excluded,
as p-cresol absorbs light up to a maximal wavelength of 300 nm
(maxima at 221 and 274 nm), whereas luminol-dependent chemi-
luminescent light is emitted at 425 nm.
The dose-response curves for other compounds are illustrated
in Table 3. Only for phenol was a significant depression in CO2
production and chemiluminescence observed, but at concentra-
tions exceeding those encountered in ESRD (20 tgIml).
Evaluation of the effect of p-cresol (N = 3) on cell-free
myeloperoxidase-H202 preparation revealed a markedly higher
total number of registered counts in the absence of p-cresol
(means, 10 mm 543; 20 mm 737; 30 mm 810 CPM) compared with
the presence of p-cresol (36, 96 and 99 CPM, respectively),
indicating a direct inhibition of myeloperoxidase by p-cresol.
Influence of incubation time
Incubation of whole blood with 5 gfml and 20 pg/mI p-cresol
for 10, 60 and 120 minutes before determination of CO2 produc-
tion and chemiluminescence (N = 6) resulted in a markedly
increased depression in the response to Staph A after the longer
incubation periods, compared to 10 minutes (P < 0.05; Fig. 6).
Comparison of p-cresol and o-cresol
The results of the comparative study on the effect of p-cresol
and o-cresol are illustrated in Table 4 (N = 6). A similar and
additive depressive effect is observed.
A Monocytes
a>
E
C
a)0 (1)
(2)
101
102
(3)
1 0
Log fluorescence units
(4)
1 0
400
300
200
100
0
800
600
400
200
B
C PC
Granulocytes
C
E
U,C
a)
C
a)
C)C
a)
C)
U)
a>0
IL
Fig. 2. Fluorescence emission (LFU — means per cell) in the presence of
Bursttest R control (C) vs. p-cresol (30 pg/mI) (PC) for granulocytes (A) and
monocytes (B). ** P < 0.01 vs. C.
0
C PC
514 Vanholder et al: Role of p-cresol in phagocyte function
**
** (
p-Cresol concentration, pg/mi
Fig. 3. Dose-response curve of the effect of p-cresol on the response in CO2
production versus latex (El), zymosan (L) and Staph A (0). ' P < 0.05, * p
<0.01 vs. 0 jg/ml.
Time, minutes
Fig. 4. Representative curves of chemiluminescence production in response
to Staph A in control condition (S) or in the presence of p-cresoi, 10 pg/mI
(•), 30 1ug/ml (A) or 50 pg/mi (U). For this specifIc experiment, total
recycling time was extended to 60 mm.
Studies with p-cresyisuifate
In Figure 7, the results of granulocyte stimulation by Staph A in
the presence of p-cresol and p-cresylsulfate are illustrated (N =
6). A depressive effect on granulocyte functional capacity is
observed only in the presence of p-cresol.
HPLC elution pattern of solutes used for screening
The elution pattern of the 18 different solutes is illustrated in
Table 5. The two compounds with inhibitory capacity (phenol and
p-cresol) elute in fractions 9 and 12 (retention times mm 35.0 for
phenol and mm 46.6 for p-cresol). Arginine, -endorphin, dim-
ethylamine, guanidinosuccinic acid, spermidine, spermine and
urea were all shown by light scattering analysis to elute in fraction
2. Methylguanidine eluted in fraction 3.
Discussion
The impact of 18 uremic solutes on granulocytic respiratory
burst activity and on radical species production was evaluated to
identif' influencing factor(s) acting upon the effete host defense
response of ESRD.
That uremic toxins would influence granulocyte function has
been suggested by earlier studies from our group [37] in which
uremic granulocytes were shown to have a significantly lower CO2
production compared to normal cells. In addition, function im-
proved when these uremic cells were suspended in normal plasma,
whereas HPLC-fractionation of uremic ultrafiltrate demonstrated
that at least some of the inhibitory fractions had lipophilic
characteristics.
In the present study, the most consistent dose-dependent
decrease of granulocyte function was registered for the volatile
phenolic compound p-cresol at concentrations currently encoun-
tered in uremia (Table 2, Figs. 3 to 5); at higher concentrations, a
depressive effect was also present for phenol (Table 3). The in vivo
importance of p-cresol may even be more prominent, since
granulocytes are in contact with these metabolites for longer
periods than the time limitations for incubation respected in this
study. This was confirmed by results obtained with longer incuba-
tion times for p-cresol, which caused a profound depression of
granulocyte function (Fig. 6), and was confirmed with three
different methods (CO2 production, chemiluminescence, flow
cytometry).
The "deactivation" by p-cresol is well delineated in response to
three different particles (latex, zymosan, Staph A) as well as to the
soluble, non-phagocytic, direct protein kinase C activator PMA
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.1
*
**
**
**
**
t-.
I
60
50
40
30
20
10
**
**
I..
120
100
80
60
40
20
0
- -f"
*
*
**
0 10 20 30 40 50 0 10 20 30 40 50 60
Vanholder et al: Role of p-cresol in phagocyte function 515
Table 3. Dose-response curves (14C02 production and
chemiluminescence) (Staph A)
Id I
'/,
/'.<::
':7/, I
13-endorphin pg/ml 0 0.5 x i0 1 x i0 8 x i0
DPM 90 22 92 22 84 15 91 20
CHEM 139 31 160 43 159 43 163 37
Creatinine pg/mI 0 50.0 100.0 200.0
DPM 63±6 57±4 64±7 59±6
CHEM 76 23 92 34 — 85 31
Phenol jig/mI 0 5.0 10.0 20.0
DPM 54±8 55±3 53±8 383h
CHEM 76 18 75 20 — 61 14"
Spermidine pg/mi 0 25.0 100.0 800.0
DPM 65 19 77 20 68 17 65 17
CHEM 159 38 157 34 161 36 151 35
Spermine pg/mi 0 25.0 100.0 800.0
DPM 66 15 70 15 72 17 74 17
CHEM 138 38 141 37 142 39 126 33
Urea mg/mi 0 1.5 3.0 6.0
DPM 52 13 52 15 60 16 46 13
CHEM 91 33 88 35 — 86 22*
*
*
nfl
11±
200
x
U)
100
00
0
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3000)
1)
E 200
100
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2 100
x
>
0
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Fig. 5. Dose-response curves of the effect of p-cresol on chemiluminescence
production in response to Staph A.
(Table 2, Fig. 3). Among the stimuli studied, Staph A is one of the
most frequent and most morbid invading microorganisms in
dialyzed uremics [38, 39]. The parallel depression of the response
versus various stimuli, suggests a metabolic defect as the major
component. In accordance with this hypothesis, no change was
observed for flow cytometric analysis of particle ingestion (Burst-
testR)
The decrease in 14C02 production after metabolism of glucose
(Fig. 3), together with the drop in chemiluminescence (Figs. 4 and
5) and of flow cytometric data of BursttestR related to free radical
release (Figs. 1 and 2) point to an inadequate production of
reactive oxygen species, including superoxide ions, via the
NADPH oxidase system [40—43]. It has been demonstrated by
*
*
flh
Abbreviations are: DPM, disintegrations per minute (X 10) at study of
'4C02 production; CHEM, chemiluminescence production, peak value xio.
aN = 5 except for urea and phenol, N = 6
"P < 0.05 vs. control (0 mg or jig/mi)
Lascelles and Taylor and by Hicks et al that p-cresol inhibits
respiratory 02 uptake in various tissues [44, 45]. The respiratory
burst, a principally oxygen-dependent process, may be depressed
if the delivery of oxygen to the responsive metabolic processes
becomes a rate limiting factor.
The depressed phagocytic response could be at least in part
attributed to a depression of the activity of myeloperoxidase. Chemi-
luminescence emission after contact of H202 and myeloperoxidase
in a cell free system was markedly depressed in the presence of
p-cresol. On the other hand, the possibility that 02 substrate
delivery to myeloperoxidase is also diminished, due to the lower
glucose breakdown by HMS in response to respiratory burst should
also be considered. An intrinsic failure of HMS is hereby less
probable, as no decrease in basic HMS activity of red blood cells was
observed. Our data point to a decreased intrinsic activity of the
protein kinase C—NADPH-oxidase-myeloperoxidase axis.
The effect of both o-cresol and p-cresol is similar and cumula-
tive (Table 4), whereas the effect of phenol is less pronounced at
identical concentrations (Table 3), which suggests that the pres-
ence of the methyl side chain in o- and p-cresol is more important
for the depressive action on the respiratory burst than the position
of the hydroxyl group. These structural variations affect hydrophi-
licity/hydrophobicity, the OH group increasing and the CH3
decreasing polarity. In agreement with this, HPLC with formiate!
methanol gradient results in the elution of p-cresol and o-cresol at
high proportional concentrations of methanol, pointing to their
hydrophobicity. Polar, water soluble compounds, will have more
difficulty to enter cells. This may result in differences in penetra-
tion of the cell membrane and/or interaction with the enzyme
systems active in the membrane.
P-cresol is an intestinal, hepatic and extra-hepatic metabolite of
tyrosine, tyramine and phenylalanine [46—48], the main extra-
intestinal source of the latter compounds being muscle breakdown
[48]. Intestinal production is by bacterial degradation of ingested
proteins [49]. Further metabolic transformation of p-cresol results
in its conjugation, mainly to sulfate esters in the liver, and their
concentration in uremic sera and ultrafiltrates are virtually the
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Fig. 7. CO2 production in response to Staph A in the presence of p-
cresylsulfate (pCS 30 pg/mI), p-cresol (pC 30 pg/mI) and both p-cresol and
p-cresylsulfate together (pCS + pC, both at 30 pg/mI). P < 0.01 vs.
B control (C).
Latex Zymosan Staph A PMA
Control 53 11 136 26 123 18 108 19
+ p-cresol30 pg/mI 30±7 72 12 74 9 91 15
+o-cresol 30 pg/mI
+ p-cresol and o-
30±6
24 6ab
68±12
51 9' 65±961 8 97±1981 15b
cresol both 30 pg/mi
Table 5. HPLC elution pattern of the solutes used for screening of
their effect on PMNL function (progressive gradient from 100% formic
acid (fraction 1) to 100% methanol (fraction 15)
Fraction
N
Elution time
mm
Formiate
% Methanol Compound
2 4—8 95—89 5—11 arginine
13-endorphin
creatinine
dimethylamine
guanidinosuccinic acid
spermidine
spermine
urea
3 8—12 90—84 11—16 methylguanidine
pseudouridine
uric acid
4 12—16 84—79 16—21 tyrosine
6 20—24 73—68 27—32 tryptophan
hippuric acid
7 24—28 68—63 32—37 indoxyl sulfate
8 28—32 63—57 37—43 o-OH hippuric acid
9 32—36 57—52 43—48 phenol
12 44—48 41—32 59—68 p-cresol
failure [50, 51]. Furthermore, detoxification by conjugation may
be altered in hepatic failure. Defects in hexose monophosphate
shunt oxidation and leucine uptake by leukocytes characterize the
failure of host-defense in hepatic failure [52]. This extends the
potential pathophysiological influence of p-cresol on immune
defense beyond the scope of the uremic syndrome.
Reprint requests to K Vanholder, Nephrology Department, University
Hospital, De Pintelaan 185, B9000 Ghent, Belgium.
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